404 related articles for article (PubMed ID: 27129098)
61. The structure and function of frataxin.
Bencze KZ; Kondapalli KC; Cook JD; McMahon S; Millán-Pacheco C; Pastor N; Stemmler TL
Crit Rev Biochem Mol Biol; 2006; 41(5):269-91. PubMed ID: 16911956
[TBL] [Abstract][Full Text] [Related]
62. Does oxidative stress contribute to the pathology of Friedreich's ataxia? A radical question.
Armstrong JS; Khdour O; Hecht SM
FASEB J; 2010 Jul; 24(7):2152-63. PubMed ID: 20219987
[TBL] [Abstract][Full Text] [Related]
63. Mitochondrial dysfunction in Friedreich's ataxia: from pathogenesis to treatment perspectives.
Lodi R; Rajagopalan B; Bradley JL; Taylor DJ; Crilley JG; Hart PE; Blamire AM; Manners D; Styles P; Schapira AH; Cooper JM
Free Radic Res; 2002 Apr; 36(4):461-6. PubMed ID: 12069111
[TBL] [Abstract][Full Text] [Related]
64. Assembly and iron-binding properties of human frataxin, the protein deficient in Friedreich ataxia.
Cavadini P; O'Neill HA; Benada O; Isaya G
Hum Mol Genet; 2002 Feb; 11(3):217-27. PubMed ID: 11823441
[TBL] [Abstract][Full Text] [Related]
65. The expression of human mitochondrial ferritin rescues respiratory function in frataxin-deficient yeast.
Campanella A; Isaya G; O'Neill HA; Santambrogio P; Cozzi A; Arosio P; Levi S
Hum Mol Genet; 2004 Oct; 13(19):2279-88. PubMed ID: 15282205
[TBL] [Abstract][Full Text] [Related]
66. Lymphoblast Oxidative Stress Genes as Potential Biomarkers of Disease Severity and Drug Effect in Friedreich's Ataxia.
Hayashi G; Cortopassi G
PLoS One; 2016; 11(4):e0153574. PubMed ID: 27078885
[TBL] [Abstract][Full Text] [Related]
67. Friedreich ataxia: a paradigm for mitochondrial diseases.
Puccio H; Koenig M
Curr Opin Genet Dev; 2002 Jun; 12(3):272-7. PubMed ID: 12076669
[TBL] [Abstract][Full Text] [Related]
68. Primary and secondary drug screening assays for Friedreich ataxia.
Cotticelli MG; Rasmussen L; Kushner NL; McKellip S; Sosa MI; Manouvakhova A; Feng S; White EL; Maddry JA; Heemskerk J; Oldt RJ; Surrey LF; Ochs R; Wilson RB
J Biomol Screen; 2012 Mar; 17(3):303-13. PubMed ID: 22086726
[TBL] [Abstract][Full Text] [Related]
69. Friedreich ataxia: the oxidative stress paradox.
Seznec H; Simon D; Bouton C; Reutenauer L; Hertzog A; Golik P; Procaccio V; Patel M; Drapier JC; Koenig M; Puccio H
Hum Mol Genet; 2005 Feb; 14(4):463-74. PubMed ID: 15615771
[TBL] [Abstract][Full Text] [Related]
70. Overexpression of Drosophila frataxin triggers cell death in an iron-dependent manner.
Edenharter O; Clement J; Schneuwly S; Navarro JA
J Neurogenet; 2017 Dec; 31(4):189-202. PubMed ID: 28838288
[TBL] [Abstract][Full Text] [Related]
71. Therapeutic approaches for the treatment of Friedreich's ataxia.
Strawser CJ; Schadt KA; Lynch DR
Expert Rev Neurother; 2014 Aug; 14(8):949-57. PubMed ID: 25034024
[TBL] [Abstract][Full Text] [Related]
72. Ferroptosis in Friedreich's Ataxia: A Metal-Induced Neurodegenerative Disease.
La Rosa P; Petrillo S; Fiorenza MT; Bertini ES; Piemonte F
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33202971
[TBL] [Abstract][Full Text] [Related]
73. Mitochondrial frataxin interacts with ISD11 of the NFS1/ISCU complex and multiple mitochondrial chaperones.
Shan Y; Napoli E; Cortopassi G
Hum Mol Genet; 2007 Apr; 16(8):929-41. PubMed ID: 17331979
[TBL] [Abstract][Full Text] [Related]
74. Extra-mitochondrial mouse frataxin and its implications for mouse models of Friedreich's ataxia.
Weng L; Laboureur L; Wang Q; Guo L; Xu P; Gottlieb L; Lynch DR; Mesaros C; Blair IA
Sci Rep; 2020 Sep; 10(1):15788. PubMed ID: 32978498
[TBL] [Abstract][Full Text] [Related]
75. Targeting NRF2 for the Treatment of Friedreich's Ataxia: A Comparison among Drugs.
Petrillo S; D'Amico J; La Rosa P; Bertini ES; Piemonte F
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31640150
[TBL] [Abstract][Full Text] [Related]
76. Frataxin, a molecule of mystery: trading stability for function in its iron-binding site.
Lane DJ; Richardson DR
Biochem J; 2010 Feb; 426(2):e1-3. PubMed ID: 20141512
[TBL] [Abstract][Full Text] [Related]
77. Frataxin knockdown in human astrocytes triggers cell death and the release of factors that cause neuronal toxicity.
Loría F; Díaz-Nido J
Neurobiol Dis; 2015 Apr; 76():1-12. PubMed ID: 25554687
[TBL] [Abstract][Full Text] [Related]
78. Iron regulatory protein 1 sustains mitochondrial iron loading and function in frataxin deficiency.
Martelli A; Schmucker S; Reutenauer L; Mathieu JRR; Peyssonnaux C; Karim Z; Puy H; Galy B; Hentze MW; Puccio H
Cell Metab; 2015 Feb; 21(2):311-323. PubMed ID: 25651183
[TBL] [Abstract][Full Text] [Related]
79. Therapeutic Prospects for Friedreich's Ataxia.
Zhang S; Napierala M; Napierala JS
Trends Pharmacol Sci; 2019 Apr; 40(4):229-233. PubMed ID: 30905359
[TBL] [Abstract][Full Text] [Related]
80. Iron-dependent regulation of frataxin expression: implications for treatment of Friedreich ataxia.
Li K; Besse EK; Ha D; Kovtunovych G; Rouault TA
Hum Mol Genet; 2008 Aug; 17(15):2265-73. PubMed ID: 18424449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
